Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14330211 | 0.89 | ALOX15 (0.35) | ALOX15 | |
| SCHEMBL14330210 | 0.75 | ALOX15 (0.48) | MAPK1ALOX15GGPS1MEN1ALDH1A1 | |
| SCHEMBL1448778 | 0.75 | MAPK1 (0.32) | MAPK1ALOX15 | |
| SCHEMBL4277832 | 0.71 | — | — | |
| SCHEMBL1698052 | 0.71 | KMT2A (0.41) | MAPK1ALOX15GGPS1MEN1ALDH1A1 | |
| SCHEMBL17058709 | 0.70 | ALOX15 (0.44) | MAPK1ALOX15MEN1ALDH1A1TSHR | |
| SCHEMBL5689294 | 0.70 | L3MBTL1 (0.37) | MAPK1ALOX15MEN1ALDH1A1TSHR | |
| SCHEMBL1659356 | 0.69 | BTN3A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL2012222 | 0.69 | — | — | |
| SCHEMBL1659354 | 0.69 | BTN3A1 (0.33) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994793-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2018-06-12 | — | — | US | disclosed |
| US-20160326458-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-11-10 | — | — | US | disclosed |
| US-20150141310-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2015-05-21 | — | — | US | disclosed |
| US-8987187-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2015-03-24 | — | — | US | disclosed |
| US-20110308556-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141310-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | MAPK1 4423/4885ALOX15 599/4885MMP1 2221/4885 |
| US-20110308555-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | MAPK1 4423/4885ALOX15 599/4885MMP1 2221/4885 |
| US-20110308556-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | MAPK1 4423/4885ALOX15 599/4885MMP1 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.